R&D/Clinical Trials

Latest News

Image credit: peterschreiber.media | stock.adobe.com. Motiv COPD - Lunge und Bronchien
FDA Grants Priority Review to Dupixent for Uncontrolled Chronic Obstructive Pulmonary Disease

February 23rd 2024

The FDA has assigned a supplemental Biologics License Application submitted by Regeneron and Sanofi for Dupixent in the treatment of COPD with type 2 inflammation with a PDUFA date of June 27, 2024.

Image credit: tashatuvango | stock.adobe.com. Diagnosis - Typhoid Fever. Medical Concept. 3D Render.
WHO Grants Prequalification to Typhoid Vaccine Developed by SK bioscience, International Vaccine Institute

February 23rd 2024

Study Finds Parkinson Disease Drug Nearly Matches Wegovy in Weight Loss Effects
Study Finds Parkinson Disease Drug Nearly Matches Wegovy in Weight Loss Effects

February 22nd 2024

Image credit: Arif Biswas | stock.adobe.com
Treadwell Therapeutic's Novel Acute Myeloid Leukemia Treatment Granted FDA Orphan Drug Designation

February 22nd 2024

Liam Kaufman
Digital Biomarkers and Alzheimer’s Research: Q&A With Liam Kaufman, VP of Clinical Sciences at Cambridge Cognition

February 22nd 2024

Video Interviews
Podcasts

More News